Novel therapies for diaphragm failure in muscular dystrophy
Novel therapies for diaphragm failure in muscular dystrophy
批准号:
451388
负责人:
Petrof Basil J
金额:
$66.04万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2021
资助国家:
加拿大
项目状态:
未结题
起止时间:
2021-09-01 至 2026-09-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Duchenne muscular dystrophy (DMD), the most common genetic muscle disease, is lethal with no cure at this point in time. Most patients succumb to respiratory failure, which is caused by gradual destruction of the diaphragm, the main breathing muscle. The
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Understanding the basis of diaphragmatic weakness in critical illness
-
批准号:407809
-
项目类别:Operating Grants
-
资助金额:$52.94万
-
财政年份:2019
-
负责人:Petrof Basil J
-
依托单位:
Novel strategies for treating respiratory muscle failure in muscular dystrophy
-
批准号:345102
-
项目类别:Operating Grants
-
资助金额:$54.86万
-
财政年份:2016
-
负责人:Petrof Basil J
-
依托单位:
Ventilator-induced diaphragmatic dysfunction.
-
批准号:254195
-
项目类别:Operating Grants
-
资助金额:$52.61万
-
财政年份:2012
-
负责人:Petrof Basil J
-
依托单位:
Strategies for therapy of respiratory muscle failure in muscular dystrophy.
-
批准号:224222
-
项目类别:Operating Grants
-
资助金额:$51.65万
-
财政年份:2011
-
负责人:Petrof Basil J
-
依托单位:
Mitochondrial function as a therapeutic target in muscular dystrophy.
-
批准号:181526
-
项目类别:Operating Grants
-
资助金额:$30.71万
-
财政年份:2009
-
负责人:Petrof Basil J
-
依托单位:
海外基金